相关实验视频

Updated: Jun 28, 2025

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension

Published on: February 11, 2017

NKX2-5调节了与硬化皮相关的肺动脉高血压中的血管改造

Ioannis Papaioannou¹, Athina Dritsoula¹, Ping Kang¹

¹Division of Medicine, Department of Inflammation, University College London, Royal Free Campus, London, United Kingdom.

|April 23, 2024

概括

NKX2-5是一个关键的转录因子,在肺动脉高血压中驱动血管光滑肌肉细胞变化. 准NKX2-5可能为血管疾病提供新的治疗方法.

科学领域:

心血管生物学心血管生物学
分子生物学分子生物学
发展生物学发展生物学

背景情况:

NKX2-5是发育过程中至关重要的转录因子.
血管光滑肌细胞 (VSMC) 功能障碍有助于血管重塑和肺动脉高血压 (PAH) 等疾病.
在患有硬化症的PAH患者中,NKX2-5的水平升高.

研究的目的:

研究NKX2-5在VSMC表型调制中的作用.
在体内探索NKX2-5在血管重塑中的功能.
为了确定调节NKX2-5表达的信号通路.

主要方法:

使用培养的VSMC进行体外研究,以评估增殖,迁移,收缩性和基因表达.
在体内研究涉及条件删除NKX2-5在慢性缺氧诱导的肺高血压的小鼠模型.
分析包括TGF-β,ERK5和PI3K在内的信号通路.

主要成果:

在VSMC中抑制NKX2-5减少了增殖和迁移,增加了收缩性,并减少了细胞外基因表达.
过度表达NKX2-5具有相反的影响,抑制收缩基因和增强矩阵基因.
在体内,NKX2-5的缺失在低氧模型中减弱了血管重塑和高血压的发展.
像血清,低汇合,TGF-β和缺氧等损伤信号上调NKX2-5,TGF-β的影响由ERK5和PI3K调节.

结论:

在病理性血管重塑过程中,NKX2-5在VSMC表型调制中发挥着关键作用.
NKX2-5是血管病变的潜在治疗标,包括PAH.
通过损伤信号和途径了解NKX2-5的调节,可以了解疾病机制.

关键词:

心血管疾病是什么心血管疾病在高血压的高血压.肺部病理学肺部病理学血管生物学血管生物学

更多相关视频

Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies

Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies

Published on: May 24, 2021

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...